Company Profile

Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, listed on the Hong Kong Stock Exchange, stock code: 0455) implements the following development strategies: development of Traditional Chinese medicine (“TCM”) as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services. It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.

Tianda Pharmaceuticals forges the entire TCM industrial chain from Chinese medicine, Chinese Medicinal herbs to the application of artificial intelligence in TCM. It has established the "Tianda standard", a Chinese medicinal herbs quality control standard, and the modern Chinese medicine clinic - TDMall. As a TCM treatment and health management platform, TDMall practices TCM by adhering to the philosophy that “a great physician treats an illness before it develops”, following the treatment principle of “medication should be stopped once its efficacy shows and treatment should be centred on the patient”. Based in the Guangdong-Hong Kong-Macau Greater Bay Area, TDMall applies domestic and international strategic business plan and strives to develop into the leading brand of Chinese medicine clinic. Making full use of Internet information technology, big data, artificial intelligence and other innovative technologies, Tianda Pharmaceuticals has built "TDMall on Cloud" to implement the integration of online and offline TCM services, remote diagnosis and treatment and expert consultation, which provides a high-quality, convenient and comprehensive TCM health services for the general public, becoming a forerunner in the promotion of TCM inheritance, innovation and development.


Shares and Details

【Important Notice】 Phishing Email Alert (9 March 2023)

We, Tianda Pharmaceuticals Limited, are aware that there have been some fraudulent (phishing) emails disguised to be us, requesting the recipient to open attachments or click links fishing for personal information and/or passwords.

These phishing emails have no connection with us whatsoever, and we have reported the case to the police forces in Hong Kong, the Mainland China, and Australia.

You are advised not to reply or open any attachments or links from suspicious emails. Please stay vigilant. We will never ask for your passwords online under any circumstances. Do not give away your personal information or password to anyone.

If you suspect you have provided personal information or paid to suspicious websites or illegal units, please contact us at (852) 2545 3313 for assistance or report this to any local Police Force immediately.

Tianda Pharmaceuticals Limited